{"public_id":"cl_53b1ac86661b64f94b5e4d92d44cc582","status":"active","superseded_by_public_id":null,"corpus_id":382332,"text":"BRAF-mutant melanomas are highly dependent on B-RAF kinase activity.","confidence":0.95,"paper":{"corpus_id":382332,"title":"Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma","url":"https://sah.borca.ai/papers/382332"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_00ff9a6ecf5bc4d21ea87fbc21c7fe21","name":"B-RAF kinase activity","description":"Kinase signaling activity of the B-RAF protein targeted by the inhibitor.","types":["molecular activity"],"url":"https://sah.borca.ai/concepts/co_00ff9a6ecf5bc4d21ea87fbc21c7fe21"},{"public_id":"co_0907c6d54ef74d50ebb81fa9ae41977a","name":"BRAF-mutant melanomas","description":"Melanomas harboring activating BRAF mutations.","types":["cancer subtype"],"url":"https://sah.borca.ai/concepts/co_0907c6d54ef74d50ebb81fa9ae41977a"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_53b1ac86661b64f94b5e4d92d44cc582"}